Trending Articles

article thumbnail

Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding

Covalent Modifiers

Pasquale A. Morese, Ayaz Ahmad, Mathew P. Martin, Richard A. Noble, Sara Pintar, Lan Z. Wang, Shangze Xu, Andrew Lister, Richard A. Ward, Agnieszka K. Bronowska, Martin E. M. Noble, Hannah L. Stewart & Michael J. Waring Commun Chem 8 , 111 (2025). [link] The discovery of targeted covalent inhibitors is of increasing importance in drug discovery.

Drugs 130
article thumbnail

Eight or more drinks per week linked to signs of injury in the brain

Science Daily: Pharmacology News

Heavy drinkers who have eight or more alcoholic drinks per week have an increased risk of brain lesions called hyaline arteriolosclerosis, signs of brain injury that are associated with memory and thinking problems, according to a new study.

303
303
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What if we find nothing in our search for life beyond Earth?

Science Daily: Pharmacology News

What if we spend decades building advanced telescopes to search for life on other planets and come up emptyhanded? A recent study exploring what we can learn about life in the universe -- even if we don't detect signs of life or habitability. Using advanced statistical modeling, the research team sought to explore how many exoplanets scientists should observe and understand before declaring that life beyond Earth is either common or rare.

Research 178
article thumbnail

A New UV Light May Help Stop Future Pandemics

Drugs.com

THURSDAY, April 10, 2025 -- Five years after COVID-19 first hit the United States, scientists are already brainstorming how to stop the next big virus.One possible solution? A special kind of ultraviolet light called far-UVC, CBS News.

286
286
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

RFK Jr. won’t appear before Senate panel this week

BioPharma Drive: Drug Pricing

HELP committee chair Bill Cassidy, R-La., had invited Kennedy to testify April 10 on the sweeping layoffs of federal health workers Kennedy ordered last month. A hearing could still take place later.

284
284

More Trending

article thumbnail

Molecular Pharmacology of the Antibiotic Fosfomycin, an Inhibitor of Peptidoglycan Biosynthesis

Covalent Modifiers

Dennis H. Kim and Watson J. Lees Biochemistry 2025 DOI: 10.1021/acs.biochem.4c00522 The antibiotic fosfomycin is an epoxy-phosphonate natural product with a broad spectrum of antibacterial activity and distinct mechanism of action that has been in clinical use for 50 years. Fosfomycin is an irreversible covalent inhibitor of UDP-GlcNAc enolpyruvyl transferase (MurA), which catalyzes the first committed step in bacterial peptidoglycan biosynthesis.

article thumbnail

CDC Urges Extra Measles Shot for Some U.S. Travelers Amid Outbreak

Drugs.com

FRIDAY, April 11, 2025 -- The U.S. Centers for Disease Control and Prevention (CDC) now recommends extra measles protection for people traveling to areas with active outbreaks in the United States, CBS News reported.In an April 8 letter, the CDC.

Disease 275
article thumbnail

US risks losing biotech edge to China, report warns

BioPharma Drive: Drug Pricing

“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.

253
253
article thumbnail

Drafting Effective Drug Patent Applications: Turning Science into Market Power

Drug Patent Watch

"Just spent the morning digging into the world of pharmaceuticals and I'm blown away by the complexities of drafting effective drug patent applications. The team at Drug Patent Watch has done an incredible job of breaking down the key considerations for turning scientific discoveries into market power. From understanding the nuances of patent law to leveraging data-driven strategies, it's clear that the stakes are high in this space.

Science 87
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Chatbot opens computational chemistry to nonexperts

Science Daily: Pharmacology News

A web platform uses a chatbot to enable any chemist -- including undergraduate chemistry majors -- to configure and execute complex quantum mechanical simulations through chatting.

article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

As our understanding of the underlying biology of disease grows more sophisticated, emerging therapies operate on increasingly complex biopathological systems and mechanisms. Advanced strategies and tools are being implemented to establish the safety and efficacy of new therapeutic modalities, with the development of new biomarkers becoming one of the most relevant approaches for enhancing the precision and utility of early-stage studies.

article thumbnail

Health Secretary Says Some Cuts to CDC Will Be Reversed

Drugs.com

MONDAY, April 7, 2025 -- Some recent cuts at U.S. government health agencies may be reversed, including a key program that tracks lead exposure in children, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said last week.The lead.

article thumbnail

FDA plans to phase out animal testing for some drugs

BioPharma Drive: Drug Pricing

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin Makary was sworn in.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Avoiding Metadata Contention in Unity Catalog

Perficient: Drug Development

Metadata contention in Unity Catalog can occur in high-throughput Databricks environments, slowing down user queries and impacting performance across the platform. Our Finops strategy shifts left on performance. However, we have found scenarios where clients are still experiencing query slowdowns intermittently and even on optimized queries. As our client’s lakehouse footprint grows, we are seeing an emerging pattern where stress on Unity Catalog can have a downstream drag on performance a

article thumbnail

Mediterranean hunter gatherers navigated long-distance sea journeys well before the first farmers

Science Daily: Pharmacology News

Evidence shows that hunter-gatherers were crossing at least 100 kilometers (km) of open water to reach the Mediterranean island of Malta 8,500 years ago, a thousand years before the arrival of the first farmers.

291
291
article thumbnail

A predictive model for thiol reactivity of N-heteroaryl α-methylene–γ-lactams—a medicinally relevant covalent reactive group

Covalent Modifiers

Meehan, M.; Scofield, G.; Stahl, C.; Wolfe, J.; Horne, W. S.; Liu, P.; Brummond, K. ChemRxiv 2025. [link] Herein, we present a systematic study on the effects of electronically diverse heteroarenes on the rate of glutathione (GSH) addition to novel N-heteroaryl methylene-lactam covalent reactive groups (CRGs). Despite their unique electronic and drug-like properties, heteroarenes have not been extensively studied as handles for systematically tuning the reactivity of CRGs.

Drugs 133
article thumbnail

Mehmet Oz Confirmed as Head of Centers for Medicare & Medicaid Services

Drugs.com

TUESDAY, April 8, 2025 -- The U.S. Senate has confirmed the appointment of Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services (CMS), according to a report from The New York Times.The TV celebrity doctor and cardiothoracic.

Doctors 262
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts

BioPharma Drive: Drug Pricing

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical institutional knowledge at the FDA.

FDA 208
article thumbnail

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

The challenge of GPCR drug discovery G protein-coupled receptors (GPCRs) are one of the most desirable and challenging target classes in drug discovery, as their mutation can lead to a wide range of diseases such as cancer, cardiovascular disorders and neurological conditions. GPCRs are a large family of cell surface receptors that play a key role in transmitting signals from the outside of a cell to its interior.

article thumbnail

Researchers demonstrate the UK's first long-distance ultra-secure communication over a quantum network

Science Daily: Pharmacology News

Researchers have successfully demonstrated the UK's first long-distance ultra-secure transfer of data over a quantum communications network, including the UK's first long-distance quantum-secured video call.

Research 287
article thumbnail

Drug Discovery Industry Roundup with Barry Bunin — April 8th, 2025

Collaborative Drug

Drug Discovery Industry Roundup with Barry Bunin April 8th, 2025

Drugs 130
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

New Visual Test For Autism Could Aid Earlier Diagnosis

Drugs.com

FRIDAY, April 11, 2025 -- How children respond to movement could provide an early means of detecting autism, a new study says.Children with autism are known to prefer watching repetitive movements over random movements, researchers said.Using.

Research 256
article thumbnail

Tango Therapeutics cuts nearly one-fifth of staff

BioPharma Drive: Drug Pricing

“We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.

Marketing 176
article thumbnail

ACI’s 23rd Advanced Summit on Life Sciences Patents

FDA Law Blog: Biosimilars

Come together with leaders from the pharmaceutical, biotechnology, and diagnostic industries to unpack huge changes at the American Conference Institutes 23rd Advanced Summit on Life Sciences Patents , which is scheduled to take place from May 19-20, 2025 at the New York Bar Association in New York, NY. In a year of major change and outstanding questions, growing scrutiny on patent protection and drug pricing, and uncertainty around global price control measures and the Inflation Reduction Act,

Science 59
article thumbnail

Ancient tools from a South African cave reveal connections between prehistoric people

Science Daily: Pharmacology News

In a cave overlooking the ocean on the southern coast of South Africa, archaeologists discovered thousands of stone tools, created by ancient humans roughly 20,000 years ago. By examining tiny details in the chipped edges of the blades and stones, archaeologists are able to tell how the tools were made -- which revealed that people were sharing crafting techniques over wide distances.

281
281
article thumbnail

Why speed and clinical accuracy of information and data is critical for physicians

Fierce BioTech

Why speed and clinical accuracy of information and data is critical for physicians Learn how speed and accuracy of clinical information is transforming healthcare delivery and how your brand can become part of these high-value clinical conversations at the point of decision-making. Download now. sdees Mon, 04/07/2025 - 10:57 Learn how speed and accuracy of clinical information is transforming healthcare delivery and how your brand can become part of these high-value clinical conversations at the

FDA 52
article thumbnail

Experimental Drug Can Slow MS Disability

Drugs.com

WEDNESDAY, April 9, 2025 -- An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests.The drug, tolebrutinib, delayed disability.

article thumbnail

GSK targets neurodegenerative diseases with latest licensing deal

BioPharma Drive: Drug Pricing

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across the blood-brain barrier.

Licensing 167
article thumbnail

CDD Vault Update (April 2025): Biphasic Curve Fit, Import Parser Sections, Custom Calculation Functions, Generate Inventory Labels, Inventory Admin Permission

Collaborative Drug

CDD Update March #2 2025 Full Atom Layout of Macromolecules New Dataset for AI Similarity Searching Import Inventory Locations by Unique Box Names:

100
100